Edition:
United Kingdom

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

12.27USD
16 Nov 2018
Change (% chg)

$0.24 (+2.00%)
Prev Close
$12.03
Open
$11.91
Day's High
$12.34
Day's Low
$11.77
Volume
277,504
Avg. Vol
279,578
52-wk High
$22.75
52-wk Low
$9.64

Chart for

About

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $1,380.17
Shares Outstanding(Mil.): 59.75
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -2.48 -- --
ROI: -72.82 -0.64 15.05
ROE: -73.07 0.08 16.62

Earnings vs. Estimates